Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
8
Number of overlapping holdings
12.7%
% of XLV's 64 holdings also in XDNA
34.8%
% of XDNA's 23 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in XDNA |
Overlap | |
---|---|---|---|---|
THERMO FISHER SCIENTIFIC INC | 4.2% | 9.5% | 4.2% | |
ABBVIE INC | 5.6% | 3.8% | 3.8% | |
BRISTOL-MYERS SQUIBB CO | 2.0% | 1.6% | 1.6% | |
VERTEX PHARMACEUTICALS INC | 2.0% | 1.5% | 1.5% | |
REGENERON PHARMACEUTICALS | 1.9% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to XDNA
ELI LILLY & CO | 11.8% | |
UNITEDHEALTH GROUP INC | 7.9% | |
JOHNSON & JOHNSON | 6.9% | |
MERCK & CO. INC. | 6.1% | |
ABBOTT LABORATORIES | 3.6% | |
DANAHER CORP | 3.0% | |
PFIZER INC | 2.8% | |
AMGEN INC | 2.7% | |
INTUITIVE SURGICAL INC | 2.6% | |
ELEVANCE HEALTH INC | 2.2% |
XLV Underweight Relative to XDNA
CRISPR THERAPEUTICS AG | -15.1% | |
BEAM THERAPEUTICS, INC. | -13.7% | |
INTELLIA THERAPEUTICS, INC. | -8.7% | |
PRIME MEDICINE, INC. | -5.9% | |
EDITAS MEDICINE, INC. | -5.7% | |
THERMO FISHER SCIENTIFIC INC | -5.3% | |
CARIBOU BIOSCIENCES, INC. | -4.7% | |
VERVE THERAPEUTICS, INC. | -4.5% | |
POSEIDA THERAPEUTICS, INC. | -4.1% | |
ALLOGENE THERAPEUTICS, INC. | -3.4% |